Historical Stock Chart
3 Months : From Sep 2019 to Dec 2019
Sanofi India Ltd. (500674.BY) said it is planning to sell a pharmaceutical manufacturing facility in the western Indian state of Gujarat to Zentiva.
Sanofi India, a unit of France-based Sanofi S.A. (SAN.FR), is selling the Ankleshwar site for 2.62 billion Indian rupees ($36.4 million), the company said in a statement on Wednesday.
The Ankleshwar site has a chemistry and biotechnology development centre, and manufactures both intermediates and pharmaceutical formulations. Sanofi's Ankleshwar site manufactures more than six billion tablets annually that include painkiller brands like Combiflam.
Write to email@example.com
(END) Dow Jones Newswires
September 11, 2019 02:31 ET (06:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.